HC6: Mechanisms of adaptive immunity
T-cell activation
There are several types of lymphocytes:
- CD8 T-cell
- Mass destructors → kill cells
- B-cell
- Regulatory T-cell
- CD4 T-cell
- Mostly helper-cells → aid other cells in fighting pathogens
There are 2 types of MHC molecules, which are distinguished by their peptides being produced in 2 different cellular compartments:
- MHC class I: peptides derived from protein synthesis by the presenting cell → the antigen is produced by the cell itself
- An exception is cross-presentation of endocytosed proteins on MHC class I molecules
- Can be expressed by all nucleated cells
- CD8 T-cells bind to the a3domain of MHC class I
- The cell is infected and needs to be cleared
- MHC class II: peptides derived from endocytosed proteins → the antigen is taken up from the surroundings
- These proteins are extracellular
- Can be expressed by all antigen-presenting cells
- Dendritic cells always present MHC class II
- CD4 T-cells bind to the b2domain of MHC class II
- The cell itself isn't infected and doesn't need to be cleared
How do T-cells get activated?
Activation of the adaptive immune system starts when T-cells are activated. T-cells get activated by antigen presenting cells. Antigen presenting cells are part of the innate immune system:
- Dendritic cells, macrophages or neutrophils engulf pathogens such as bacteria and viruses and digest these to obtain antigens
- The bacteria is engulfed by a phagosome, which fuses with a lysosome that degrades the bacteria into smaller particles
- Lysosomes have enzymes and a very low pH
- The cells present the foreign antigens with MHC molecules on their surface
- A naive T-cell binds transiently to the antigen presenting cell it meets
- The TCR screens the peptide through the MHC-complex
- The TCR delivers an antigen-specific signal
- T-cell-antigen presenting cell interaction is stabilized for days
- A second signal is required to trigger activation of the naive T-cell → co-stimulation
- Co-stimulation plays an important role → the combination of an antigen-specific signal and a co-stimulatory signal is required to activate a naive T-cell
- The co-signal is derived from an alarm signal from the dendritic cell
- A B7 unit is expressed → IL-2 production
- If there isn't any B7 expression, the T-cell won't be activated
- A B7 unit has a CD80 or CD86 receptor, which will connect to CD28 on the naive T-cell
- Activated T-cells switch on the expression of various genes, including interleukin-2 (IL-2)
- IL-2 drives proliferation and differentiation of activated naive T-cells
- Naive T-cells express the low affinity IL-2 receptor, activated cells express the high-affinity receptor
- Immunosuppressive drugs act by suppressing IL-2 production or action → T-cell responses are dampened
- For example cyclosporin, tacrolimus and rapamycin
In conclusion:
- T-cells can only be activated when the antigen is presented → an antigen alone drifting near a T-cell doesn't evoke a response
- Signal 1 is the connection between the MHC molecule and the T-cell receptor
- This strongly locked by the CD4 connection
- Signal 2 is the danger signal from the dendritic cell → the B7 unit connecting to the C28
If there isn't any danger signal, the T-cell normally lets go. If it doesn't let go, there's something wrong with the T-cell because it responds to things that aren't important → the T-cell becomes anergic. It's an inactivated but alive T-cell that is unresponsive.
The presence of co-stimulatory molecules (like B7) is upregulated by microbial or pathogenic substances. They increase the expression of co-stimulatory molecules on the antigen presenting cell (APC) → they play an import role in creating danger signal in T- and B-cell activation.
Where does activation take place?
There are multiple sites involved in activation of adaptive immunity:
- Dendritic cells pick up the antigen
- The dendritic cells transport it to the draining lymph node
- In the lymph node, they stimulate adaptive immunity by presenting the antigen on their MHC molecules
- Once the right T-cell has found its antigen, the adaptive immune response kicks in
There are several pathways used by dendritic cells to process and present antigens:
- Receptor mediated endocytosis of bacteria
- Macropinocytosis of bacteria or viruses
- Viral infection
- Cross-presentation of exogenous viral antigens
- Transfer of viral antigens from infected dendritic cell to resident dendritic cell
When a T-cell has entered the lymph node, the following happens:
- T-cells enter a lymph node across high endothelial venules in the cortex
- T-cells monitor antigens presented by macrophages and dendritic cells
- Endothelial cells start expressing receptors which T-cells can use to enter the lymph node
- T-cells that do not encounter a specific antigen leave the node in the efferent lymph
- T-cells that encounter a specific antigen proliferate and differentiate to effector cells
This whole process takes about 4 days for naive T-cells → adaptive immunity takes some time to kick in. Memory cells can get activated quicker.
What happens when T-cells get activated?
After a T-cell is activated, the following happens:
- Proliferation
- Cell division and clonal expansion
- Differentiation: depending on the pathogen, the necessary function is different → different kinds of T-cells are made
- Death
- Important for down-regulation of immune response
Mature dendritic cells can activate CD4 T-cells:
- A mature dendritic cell presents its antigen via the MHC class II molecule to a naive CD4 T-cell
- The naive CD4 T-cell is activated and proliferates
- This is all dependent of the IL-2 cytokine
- Depending on the cytokines present in the micro-environment, the T-cell differentiates to a type of T-cell
- Th1-cell: a T-helper cell important for fighting intracellular pathogens
- Th2-cell: a T-helper cell for B-cell responses against extracellular pathogens
- Promotes production of antibodies by B-cells
- Th17-cell: a T-helper cell for combatting infections of skin and mucosa and autoinflammation
- iTreg-cell: a regulatory T-cell that dampens everything
Mature dendritic cells can also activate CD8 T-cells, cytolytic or cytotoxic T-cells. These connect to MHC class I molecules. CD8 T-cells require a stronger co-stimulatory activity than needed to activate CD4 T-cells. In case of a weak co-stimulatory activity, CD4 T-cells can help:
- CD4-derived cytokines can increase co-stimulation by for example increasing B7 on APC
- CD4-derived cytokines such as IL-2 can activate CD8-cells directly
Cytotoxic T-cells can kill several infected cells in succession:
- A cytotoxic CD8 T-cell recognizes a virus-infected cell
- The CD8 T-cell programs the first target cell to die
- The CD8 T-cell moves on to the second target cell
- The first target cell dies, the second is dying and the third is being attacked
In conclusion, activation of memory T-cells by an antigen presenting cell is less demanding than activation of naive T-cells.
B-cell activation
How do B-cells get activated?
In the first place, B-cells are activated by the crosslinking of a B-cell receptor with antigens → an antigen-specific signal. However, additional signals are required for B-cell activation → the B-cell co-receptor complex:
- CD21/CR2: actually binds to the bacteria
- CD19: a signaling chain that, once CR2 is connected, signals to the B-cell
- CD18: unknown function but is very necessary
The B-cell receptor and B-cell co-receptor cooperate in B-cell activation. For most antigens, even more signals are required → they are T-cell dependent. There are 2 types of antigens:
- T-cell independent antigens → quick, but not very high affinity
- Do not require help of T-cells for activation of B-cells
- No induction of B-cell memory
- No class switching → only produces IgM
- For example bacterial polysaccharides with repeating epitopes
- Problematic for vaccine development
- T-cell dependent antigens
- Require CD4 cells
- Induction of B-cell memory
- Class switching is possible
In case of T-cell-independent B-cell activation, B-cells become activated when their receptors are cross-linked by antigens → antibody production. This response isn't of a very high quality.
In case of T-cell-dependent B-cell activation, specialized Th2 cells stimulate the proliferation and differentiation of naive B-cells:
- A B-cell binds to an antigen and presents it on their MHC class II to the T-cells
- The TFH-cell recognizes a peptide derived from the B-cells antigen
- A TFH-cell is a follicular helper cell
- This is basically a Th2-cell
- The naive B-cell and TFH-cell exchange signals that begin the process of B-cell activation
- The B-cell starts to activate → becomes a plasma cell
The T-cell can also encounter the same antigen presented by a dendritic cell, which also will lead to it presenting IL-2 → this will eventually also activate the B-cell. In conclusion, B-cells can be activated by T-cells responding to B-cells or by T-cells responding to dendritic cells.
How is unwanted activation regulated?
During activation, multiple measures are taken to prevent unwanted responses:
- Selection during maturation in the bone marrow or thymus
- Binding to self-antigens can lead to deletion or inactivation of immature B-cells in the bone marrow
- T-cells that show affinity for MHC-molecules presented by cortex thymic epithelial cells are positively selected in the thymus
- T-cells specific for and binding too strongly to self-antigens are removed in the thymus by negative selection
- Regulation of B- and T-cell responses after the cells have left the primary lymphoid organs
- Anergy
- Regulatory T-cells that dampen the immune response
What is the function of antibodies?
Antibodies have many different effector functions:
- Neutralization of toxins → ensure that they're not recognized anymore by the immune system
- Inhibition of adherence to the epithelium
- Complementing activation
- Fc receptors and complement receptors provide opsonization
There are many immunoglobulin isotypes:
Clinical examples
Asthma:
If a Th2 response goes wrong, it can cause an immune response against an allergen that isn't dangerous. This happens in case of asthma:
- Peptides of a degraded allergen are presented by an antigen-presenting cell
- A naive T-cell starts to promote a Th2 response
- The Th2 response promotes the development of B-cells that promote the recruitment of innate immune cells
- A cascade of inflammatory responses is activated
Immunotherapy:
In case of adoptive T-cell transfer, the adaptive immune system is used as a base for cancer immunotherapy:
- Cytotoxic T-cells are taken out of the patient's body
- They're in-vitro selected for their tumor-antigen
- They're expanded in-vitro
- They're put back into the body
This creates a high amount of CD8 T-cells that have a high affinity for the tumor and starts to destroy it.
The danger signal is important to activate T-cells, but it also initiates the expression of PD-L1 on the antigen-presenting cell → it connects PD1 to PD-L1. This complex has a higher affinity for CD28 than the B7-receptor → it inhibits the activation through negative feedback. It prevents over-responsion. Tumors can take advantage of this system by starting to express PD-L1 in order to deactivate T-cells instead of killing them. By inhibiting this system, the T-cell can be reactivated again to target the tumor.